IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.
St. Luke’s University Health Network is marking a decade of leadership and transformation in patient safety through its ...
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Building on over two ...
(RTTNews) - Masimo Corporation (MASI) Monday said it received clearance from the Food and Drug Administration (FDA) for its over-the-counter monitoring system Stork for babies up to 18 months. Stork ...
Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results